Aethlon Medical Secures FDA Clearance For Amendment In Initial-Stage COVID-19 Study
The U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of the ongoing clinical trial investigating Aethlon Medical’s (NASDAQ: AEMD) lead therapy Aethlon Hemopurifier for patients with severe COVID-19.
